Although tumor CD73 is thought to exert its effects through the elevation of extracellular adenosine levels in the tumor microenvironment, adenosine levels have not yet been measured directly in tumor tissues or correlated to CD73 levels. This evidence concerns the gene NT5E and neoplasm.